REGEND THERAPEUTICS
Regend Therapeutics focuses on the human organ regenerative medicine business and is a global leader in this field. Its core product REGEND001 cell preparation has been accepted by the State Food and Drug Administration and is the world's first autologous stem cell product for respiratory diseases. The company is also the first company in China to be registered by the National Health and Health Commission and the Food and Drug Administration, and is allowed to conduct clinical research on stem c... ells (Registration No.: CMR-20161214-1002). It is also the first batch of key research and development programs of the Ministry of Science and Technology. And companies that transform research topics. At present, the company has passed ISO9001:2008 quality management system certification, and the stem cell preparation has passed the China Metrology Accreditation (CMA), China Conformity Assessment Committee (CNAS) and IAF International Mutual Recognition. All clinical programs of Jimmy Suisheng are strictly in accordance with the regulations of the National Health Care Commission and the Food and Drug Administration, and are registered with the National Trial Global Database of the National Institutes of Health.
REGEND THERAPEUTICS
Industry:
Biotechnology Health Care Therapeutics
Founded:
2015-01-01
Address:
Suzhou, Jiangsu, China
Country:
China
Website Url:
http://www.regend.cn
Status:
Active
Contact:
0512-87899182
Email Addresses:
[email protected]
Total Funding:
100 M CNY
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF Mobile Non Scaleable Content Euro ASP.NET IIS Pound Sterling ASP.NET 4.0 Japanese Yen
Similar Organizations
Affimed
Affimed Therapeutics is focused on developing recombinant antibody therapeutics for the treatment of cancer and other diseases.
AFI Japan
AFI Japan deals with development, manufacture and sale of devices that supports the industrialization of regenerative medicine.
Akebia Therapeutics
Akebia Therapeutics develops treatments for ischemia and vascular diseases.
APRINOIA Therapeutics
Biotechnology, Neuorscience
BioRegen
BioRegen develops biomedical materials, regenerative medicines .
Convalesce
Stem Cell Based Therapy for Neurodegenerative diseases
D2M Biotherapeutics
D2M Biotherapeutics focuses on the development of novel immunotherapeutics.
Dystrogen Therapeutics
Dystrogen Therapeutics is a clinical-stage regenerative medicine company focusing on rare diseases.
Endlyz Therapeutics
Endlyz Therapeutics is developing disease-modifying therapeutics for Parkinson’s disease (PD) and other dementias.
Grey Wolf Therapeutics
Small molecules to increase tumor detection by the immune system
Human Life CORD
Human Life Cord specializes in regenerative medicine.
Hummingbird Bioscience
Hummingbird Bioscience focuses on the discovery and early development of oncology drugs.
Igea Pharma
IGEA Pharma focuses on health-tech and med-tech products and devices.
IMB Dx
Liquid biopsy for early cancer detection and safe monitoring
Knowledge Palette
Knowledge Palette is a start-up company that conducts business of regenerative medicine cells.
Lysosomal Therapeutics
Lysosomal Therapeutics deliver cures for neurodegenerative diseases.
MAGiQ Therapeutics
MAGiQ Therapeutics focuses on the development and licensing of regenerative medicine products generated from iPS cells.
Mynvax
Mynvax is an Indian-based biotech startup that develops next-generation vaccines for influenza.
Omniscope
We read your immune system to intercept diseases.
Orum Therapeutics
Private biotech company creating cell penetrating therapeutic antibodies
Oxford MEStar
Oxford MEStar is specialising in translational and regenerative medicine.
Periotherapia
Periotherapia is a drug discovery business with triple negative breast cancer as the first indication.
Qyuns Therapeutics
Qyuns Therapeutics develops monoclonal antibody drugs for autoimmune diseases.
Reborna Biosciences
Reborna Biosciences is a research and development start-up focusing on the field of rare genetic diseases.
Renibus Therapeutics
Renibus Therapeutics operates in the healthcare industry focusing on the pharmaceutical business.
Renovos
Providing orthopaedic regenerative medicine solutions
SanReno Therapeutics
SanReno Therapeutics develop, manufacture and commercialize kidney disease therapies.
Seknova Biotechnology Co., Ltd.
Continuous biomarker monitoring system that offers multi-biomarker monitoring for early detection of acute complications
Semma Therapeutics
Semma Therapeutics was founded to develop transformative therapies for Type 1 diabetes patients.
STipe Therapeutics
STipe Therapeutics focuses on harnessing the innate immune system to battle cancer.
The Agency for Science, Technology and Research
The lead agency for fostering world-class scientific research.
Pragma Bio
Pragma Bio is a biotechnology company that mines microbiome drugs to treat cancer and autoimmune diseases.
Current Employees Featured
Founder
Investors List
China Merchants Securities
China Merchants Securities investment in Series B - Regend Therapeutics
Official Site Inspections
http://www.regend.cn Semrush global rank: 8.74 M Semrush visits lastest month: 261
- Host name: 139.196.38.47
- IP address: 139.196.38.47
- Location: Hangzhou China
- Latitude: 30.294
- Longitude: 120.1619
- Timezone: Asia/Shanghai
More informations about "Regend Therapeutics"
REGEND
吉美瑞生(Regend Therapeutics)近日宣布，正在中国进行的REGEND001移植治疗特发性肺纤维化（IPF）注册临床Ⅱ期试验已完成全部患者入组，预计明年年初启动Ⅲ期确证性临床试验相关 …See details»
吉美瑞生 - REGEND
Regend is a global industry leader in the field of regenerative medicine for human organs.Its core product, REGEND001 cell preparation, has been accepted by the state food and drug …See details»
吉美瑞生 - REGEND
The application for clinical trial of REGEND001 cell autotransfusion preparation, a product independently developed by the company, has been accepted by the Drug Review Center of …See details»
Company Introduction-REGEND
Regend Therapeutics' mission is to rebuild life and enhance health through innovative cell gene therapy products, aiming to lead the medical revolution in regenerative medicine and new drug …See details»
REGEND
Regend Therapeutics achieves crucial milestone with progenitor cell therapy for COPD. This trial a randomized double-blind placebo-controlled Phase II study (NCT05638776) focuses on …See details»
History-REGEND
Regend Therapeutics XLotus（Jiangxi）Co, Ltd was established in Nanchang 2019 "Adult stem cells for lung tissue regeneration" project was selected as one of the top ten advances in …See details»
Regend Therapeutics - Crunchbase Company Profile & Funding
Regend Therapeutics focuses on the human organ regenerative medicine business and is a global leader in this field. Its core product REGEND001 cell preparation has been accepted by …See details»
吉美瑞生 - REGEND
苏州吉美瑞生医学科技有限公司 (Regend Therapeutics)成立于2015年，是由国家特聘专家、长江学者、重点研发计划首席科学家领衔的海外留学归国博士团队联合创立的创新型生物医药公司 …See details»
Regend Therapeutics | BIO-Europe - Informa Connect
Regend Therapeutics is an innovative Biotech company in China. With the goal of "Reviving Life, Reshaping Health," we focus in the field of organ regeneration with progenitor cell-based …See details»
Regend Company Profile 2024: Valuation, Funding & Investors
Developer of stem cell therapy products and human organ regenerative medicine. The company is mainly engaged in research and development of regenerative medicine, providing users with …See details»
Research & Development-REGEND
Clinical research indications: At present, the company relies on the R-Clone technology platform and focuses on major refractory and traumatic diseases of the lungs and kidneys, continuously …See details»
Regend Therapeutics Co Ltd. (苏州吉美瑞生医学科技有限公司)
了解Regend Therapeutics Co Ltd. (苏州吉美瑞生医学科技有限公司)公司的药物管线，治疗领域，技术平台，以及它的18项临床试验, 38篇新闻和1篇文献，疾病领域:内分泌与代谢疾病，肿 …See details»
Overview, News & Similar companies - ZoomInfo.com
View 苏州吉美瑞生医学科技有限公司 (www.regend.cn) location in 江苏省, China , revenue, industry and description. Find related and similar companies as well as employees by title and …See details»
吉美瑞生 - REGEND
张婷 博士. 吉美瑞生创始人、总经理（ceo）、董事See details»
Regend Therapeutics - VentureRadar
"Regend is a global industry leader in the field of regenerative medicine for human organs. Clinical indications: (IPF) of Idiopathic Pulmonary Fibrosis, (COPD) of chronic obstructive …See details»
Cell Preparation-REGEND
Regend has established a stable and efficient production line of progenitor cell preparations and corresponding production andquality management system in accordance with GMP standards. …See details»
吉美瑞生-动脉网 - vbdata.cn
Jul 28, 2015 · 吉美瑞生再生医学集团（Regend Therapeutics）成立于2015年，是由国家特聘专家、长江学者、重点研发计划首席科学家领衔的海外留学归国博士团队联合创立的创新型生物医 …See details»
吉美瑞生 - regend.cn
Oct 23, 2007 · 吉美瑞生再生医学集团（Regend Therapeutics）成立于2015年，由左为教授与多名留学归国学者共同创立。 公司专注于前体细胞的人体器官再生医学领域，以开发创新的细胞 …See details»
REGEND006(REGEND006) - 在研适应症：支气管扩张_专利_临床_ …
REGEND006: 一种细胞替代物药物，由Regend Therapeutics Co Ltd. (苏州吉美瑞生医学科技有限公司)公司最早进行研发，目前全球最高研发状态为临床申请，作用机制: 细胞替代物，治疗领 …See details»
吉美瑞生 - REGEND
We can provide one-stop consultation services from research and development, registration, transformation to production, and tailor-made high-quality solutions for your products. Our …See details»